Back to Journals » Journal of Inflammation Research » Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases
Journal of Inflammation Research
- View all (4257)
- Volume 19, 2026 (438)
- Volume 18, 2025 (1174)
- Volume 17, 2024 (804)
- Volume 16, 2023 (460)
- Volume 15, 2022 (493)
- Volume 14, 2021 (541)
- Volume 13, 2020 (112)
- Volume 12, 2019 (35)
- Volume 11, 2018 (47)
- Volume 10, 2017 (20)
- Volume 9, 2016 (24)
- Volume 8, 2015 (21)
- Volume 7, 2014 (17)
- Volume 6, 2013 (14)
- Volume 5, 2012 (17)
- Volume 4, 2011 (13)
- Volume 3, 2010 (15)
- Volume 2, 2009 (6)
- Volume 1, 2008 (6)
Journal Articles:
- Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases (2)
- Neutrophils in a New Light: Emerging Roles in Inflammation (4)
- Microbiome-Immune Crosstalk: Mechanisms, Therapeutic Modulation, and Translational Strategies in Chronic Inflammatory and Infectious Diseases (1)
- Targeting the IL-4/IL-13 Axis in the Treatment of Type 2 Inflammation (8)
- Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation (7)
- Omics, Microbiome, and Artificial Intelligence: Novel Insights into Human Disease-Associated Inflammatory Responses (3)
- Inflammaging in Cardiovascular and Chronic Disease (4)
- The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation (1)
- Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes (2)
- Inflammation and brain: how inflammatory processes influence physiological and pathological functions of the central nervous system (12)
- Genetic and non-genetic inflammation networks in major human diseases (6)
- Neurodegenerative diseases: From Pathogenesis to Treatment (1)
- Unraveling the Complex Relationship Between Inflammation, Diabetes, and Obesity: A Comprehensive Exploration (2)
Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases
Lung inflammation is a hallmark characteristic feature of many respiratory diseases, from asthma and chronic obstructive pulmonary disease (COPD) to pulmonary fibrosis and acute respiratory distress syndrome (ARDS). While inflammation serves as a protective role in response to infection or injury, dysregulated or persistent inflammatory responses can lead to progressive lung damage and impaired respiratory structure and function. Understanding the cellular and molecular drivers behind lung inflammation is crucial for developing targeted therapies that can modulate these pathways without compromising host defense.
Lipoxin A4 Attenuates E. coli-Induced ARDS-Like Lung Injury in Mice via ALX/FPR2-Dependent Macrophage Reprogramming
Zhang B, Xu M, Deng Y, Li D, Shen J, Pan C, He H
Journal of Inflammation Research 2026, 19:597266
Published Date: 16 July 2026
Effects of Eosinophilopoietins and C-C Chemokines on Chemotaxis, Adhesion, and ROS Production of Blood Eosinophil Subtypes in Asthma Patients
Rimkunas A, Januskevicius A, Vasyle E, Kalinauskaite-Zukauske V, Palacionyte J, Miliauskas S, Malakauskas K
Journal of Inflammation Research 2025, 18:16187-16207
Published Date: 19 November 2025
